Use of Vitek 2 antimicrobial susceptibility profile to identify mecC in methicillin-resistant Staphylococcus aureus

51Citations
Citations of this article
120Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The emergence of mecC methicillin-resistant Staphylococcus aureus (MRSA) poses a diagnostic challenge for clinical microbiology laboratories. Using the Vitek 2 system, we tested a panel of 896 Staphylococcus aureus isolates and found that an oxacillinsensitive/cefoxitin-resistant profile had a sensitivity of 88.7% and a specificity of 99.5% for the identification of mecC MRSA isolates. The presence of the mecC gene, determined by bacterial whole-genome sequencing, was used as the gold standard. This profile could provide a zero-cost screening method for identification of mecC-positive MRSA strains. Copyright © 2013, American Society for Microbiology.

Cite

CITATION STYLE

APA

Cartwright, E. J. P., Paterson, G. K., Raven, K. E., Harrison, E. M., Gouliouris, T., Kearns, A., … Török, M. E. (2013). Use of Vitek 2 antimicrobial susceptibility profile to identify mecC in methicillin-resistant Staphylococcus aureus. Journal of Clinical Microbiology, 51(8), 2732–2734. https://doi.org/10.1128/JCM.00847-13

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free